A precipitous step deeper into the CDMO business
23/11/20 -"Wacker's Biosolutions business has become a partner of choice for German mRNA player CureVac. Currently, the technology transfer for the production of CureVac's COVID-19 vaccine candidate is being ..."
Pages
52
Language
English
Published on
23/11/20
You may also be interested by these reports :
11/11/26
Brenntag’s Q3 sales beat consensus by 6.6%, supported by higher chemical prices and favourable FX. However, operating EBITDA was broadly in line with ...
11/11/26
1Q26/27: All in all, a solid start – FY26/27E guidance confirmed
10/11/26
K+S’s Q3 2026 sales growth was driven by price and mix, not volume, as the Bethune shutdown hit volumes. De-icing refill demand lifted Industry+. ...
09/11/26
K+S (ADD; Germany) mines potash and magnesium products in Germany and at Bethune in Canada, with a salt business on the side. The shares trade as a ...